Skip to main content

Table 3 Associations between MTC02 expression results and ERG positive prostate cancer phenotype

From: High mitochondria content is associated with prostate cancer disease progression

   MCT02 IHC result  
Parameter n evaluable Negative (%) Weak (%) Moderate (%) Strong (%) p value
All cancers 3.35 1.8 12.2 33.8 52.2  
PSA preoperative       
<4 451 2.66 11.97 32.59 52.77 0.9613
4-10 2.03 1.73 12.03 34.12 52.12
10-20 604 1.66 12.75 33.44 52.15
>20 218 1.83 13.3 35.78 49.08
Tumor stage       
pT2 1.980 1.92 11.31 34.55 52.22 0.5463
pT3a 902 1.77 13.86 33.81 50.55
pT3b 427 1.64 12.41 30.68 55.27
pT4 22 0 18.18 36.36 45.45
Gleason grade       
≤3 + 3 745 3.36 10.07 36.64 49.93 0.008
3 + 4 1.98 1.26 12.32 33.01 53.41
4 + 3 485 2.06 14.85 33.81 49.28
≥4 + 4 114 0.88 13.16 32.46 53.51
Lymph node metastasis       
N0 1.9 1.63 12.2 34.56 51.6 0.7185
N+ 192 1.04 14.58 32.81 51.56
Surgical margin       
Negative 2.62 1.83 12.48 33.73 51.96 0.825
Positive 670 1.94 11.19 34.63 52.24